Learn More
Disclaimer: Any mention of organizations, equipment, products, or tech­ nologies, is for information only: it does not imply NIST recommendation or endorsement, nor does it imply that the equipment, products or tech­ nologies mentioned are necessarily the best available for the purpose ii NISTIR 6529-A In addition to the name change, which reflects more(More)
Belatacept is a B7-specific fusion protein used to prevent allograft rejection by blocking T cell costimulation. Generally efficacious, it fails to prevent acute rejection in a sizable minority of patients. In experimental models, memory T cells mediate costimulation blockade-resistant rejection (CoBRR), but this remains undefined in humans. To explore(More)
  • 1